Based on the mutational landscapes, DLBCL can be divided into subgroups characterized by genetic alterations in the proximal B-cell receptor, NF-kB signaling, PI3-kinase signaling, anti-apoptotic proteins, DNA damage repair, and immune evasion [20,21]. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.